NF2 and schwannomatosis: Of note, 5/19 SP-EPN samples that were obtained from patients with clinical NF2-related schwannomatosis did not show any NF2 mutations in NGS panel analysis, suggesting that certain genomic alterations in NF2 are not captured by NGS (Fig. 2a, left panel).